Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. USO
2. SPY
3. QTTB
4. ERAS
5. PSKY
6. BIIB
7. AAPL
8. JPM
9. NFLX
10. MU

Go back to Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial

Peregrine Pharma (PPHM) Rips Following Update on Cotara Program

December 5, 2012 8:07 AM EST

Peregrine Pharmaceuticals (NASDAQ: PPHM) shares are popping in early trading after the pharma announced significant progress is being made n advancing its Cotara program into late-stage development through its agreement with the U.S. Food and Drug Administration (FDA) on the design of a... More